Lexicon announces three presentations at Association of Diabetes conference

Lexicon Pharmaceuticals announced that three poster presentations will be delivered during the 2024 Annual Conference of the Association of Diabetes Care & Education Specialists being held August 9 – 12, 2024 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. “It’s well-established that people with type 1 diabetes and chronic kidney disease are at high risk of progression to kidney failure and cardiovascular events due to poor glycemic control,” said Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer. “We look forward to engaging with diabetes educators at the ADCES conference about this important data on the clinical effect of sotagliflozin as an adjunct to insulin in people with T1D and CKD.”